Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georges Delsol

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|March 27, 2014
Clinical analysis and prognostic significance of haemophagocytic lymphohistiocytosis-associated anaplastic large cell lymphoma in childrenClaudia Pasqualini, Veronique Minard-Colin, Veronique Saada, et al.
Cancer Biology & Therapy|July 31, 2007
Development of a conditional bioluminescent transplant model for TPM3-ALK-induced tumorigenesis as a tool to validate ALK-dependent cancer targeted therapySylvie Giuriato, Nathalie Faumont, Emilie Bousquet, et al.
Blood|November 2, 2006
Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypesLaurence Lamant, Aurélien de Reyniès, Marie-Michèle Duplantier, et al.
Medicine|May 26, 2018
Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical studyGeisilene Russano de Paiva Silva, Emilie Tournier, Luis Otávio Sarian, et al.
Genes, Chromosomes & Cancer|June 12, 2003
Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphomaLaurence Lamant, Randy D Gascoyne, Marie Michèle Duplantier, et al.
The American Journal of Pathology|February 25, 2003
Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasmsTeresa Marafioti, Stefano Ascani, Karen Pulford, et al.
Haematologica|May 30, 2013
CD30-positive peripheral T-cell lymphomas share molecular and phenotypic featuresBettina Bisig, Aurélien de Reyniès, Christophe Bonnet, et al.
Biochimie|June 20, 2012
Technical note: Hapten synthesis, antibody production and development of an enzyme-linked immunosorbent assay for detection of the natural steroidal alkaloid Dendrogenin APhilippe de Medina, Michael R Paillasse, Gregory Segala, et al.
Blood|March 13, 2010
Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemiaSylvie Giuriato, Marianne Foisseau, Emilie Dejean, et al.
Oncogene|June 23, 2004
Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cellsFlorence Armstrong, Marie-Michèle Duplantier, Pascal Trempat, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|March 27, 2014
Clinical analysis and prognostic significance of haemophagocytic lymphohistiocytosis-associated anaplastic large cell lymphoma in childrenClaudia Pasqualini, Veronique Minard-Colin, Veronique Saada, et al.
Cancer Biology & Therapy|July 31, 2007
Development of a conditional bioluminescent transplant model for TPM3-ALK-induced tumorigenesis as a tool to validate ALK-dependent cancer targeted therapySylvie Giuriato, Nathalie Faumont, Emilie Bousquet, et al.
Blood|November 2, 2006
Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypesLaurence Lamant, Aurélien de Reyniès, Marie-Michèle Duplantier, et al.
Medicine|May 26, 2018
Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical studyGeisilene Russano de Paiva Silva, Emilie Tournier, Luis Otávio Sarian, et al.
Genes, Chromosomes & Cancer|June 12, 2003
Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphomaLaurence Lamant, Randy D Gascoyne, Marie Michèle Duplantier, et al.
The American Journal of Pathology|February 25, 2003
Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasmsTeresa Marafioti, Stefano Ascani, Karen Pulford, et al.
Haematologica|May 30, 2013
CD30-positive peripheral T-cell lymphomas share molecular and phenotypic featuresBettina Bisig, Aurélien de Reyniès, Christophe Bonnet, et al.
Biochimie|June 20, 2012
Technical note: Hapten synthesis, antibody production and development of an enzyme-linked immunosorbent assay for detection of the natural steroidal alkaloid Dendrogenin APhilippe de Medina, Michael R Paillasse, Gregory Segala, et al.
Blood|March 13, 2010
Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemiaSylvie Giuriato, Marianne Foisseau, Emilie Dejean, et al.
Oncogene|June 23, 2004
Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cellsFlorence Armstrong, Marie-Michèle Duplantier, Pascal Trempat, et al.
Pageof 8